![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 34, 31020-31030, August 23, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Homodimer formation activates all
nitric-oxide synthases (NOSs). It involves the interaction between two
oxygenase domains (NOSoxy) that each bind heme and
(6R)-tetrahydrobiopterin (H4B) and catalyze NO synthesis
from L-Arg. Here we compared three NOSoxy isozymes
regarding dimer strength, interface composition, and the ability of
L-Arg and H4B to stabilize the dimer, promote its formation, and protect it from proteolysis. Urea dissociation studies
indicated that the relative dimer strengths were NOSIIIoxy
Distinct Dimer Interaction and Regulation in
Nitric-oxide Synthase Types I, II, and III*
,
,
,
¶
Department of Immunology, Lerner Research
Institute, The Cleveland Clinic, Cleveland, Ohio 44195 and the
§ Department of Molecular Biology, Skaggs Institute for
Chemical Biology, The Scripps Research Institute,
La Jolla, California 92037
NOSIoxy > NOSIIoxy (endothelial NOSoxy (eNOSoxy)
neuronal NOSOXY (nNOSoxy) > inducible NOSoxy (iNOSoxy)). Dimer strengths of the full-length NOSs had the same rank order as judged by their urea-induced loss of NO synthesis activity. NOSoxy dimers containing L-Arg plus H4B exhibited the greatest resistance to
urea-induced dissociation followed by those containing either molecule
and then by those containing neither. Analysis of crystallographic structures of eNOSoxy and iNOSoxy dimers showed more intersubunit contacts and buried surface area in the dimer interface of eNOSoxy than
iNOSoxy, thus revealing a potential basis for their different stabilities. L-Arg plus H4B promoted dimerization of
urea-generated iNOSoxy and nNOSoxy monomers, which otherwise was
minimal in their absence, and also protected both dimers against
trypsin proteolysis. In these respects, L-Arg alone was
more effective than H4B alone for nNOSoxy, whereas for iNOSoxy the
converse was true. The eNOSoxy dimer was insensitive to proteolysis
under all conditions. Our results indicate that the three NOS isozymes,
despite their general structural similarity, differ markedly in their
strengths, interfaces, and in how L-Arg and H4B influence
their formation and stability. These distinguishing features may
provide a basis for selective control and likely help to regulate each
NOS in its particular biologic milieu.
*
This work was supported by National Institutes of Health
Grants CA53914 (to D. J. S.) and HL58883-05 (to E. D. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. Tiso, A. Strub, C. Hesslinger, C. T. Kenney, R. Boer, and D. J. Stuehr BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase Mol. Pharmacol., April 1, 2008; 73(4): 1244 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Du, Y.-Y. Guan, N. J. Alp, K. M. Channon, and A. F. Chen Endothelium-Specific GTP Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression in Salt-Sensitive Low-Renin Hypertension Circulation, February 26, 2008; 117(8): 1045 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marechal, T. A. Mattioli, D. J. Stuehr, and J. Santolini Activation of Peroxynitrite by Inducible Nitric-oxide Synthase: A DIRECT SOURCE OF NITRATIVE STRESS J. Biol. Chem., May 11, 2007; 282(19): 14101 - 14112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Moens and D. A. Kass Tetrahydrobiopterin and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2439 - 2444. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, E. Y. Hayden, K. Panda, D. J. Stuehr, H. Deng, D. L. Rousseau, and S.-R. Yeh Regulation of the Monomer-Dimer Equilibrium in Inducible Nitric-oxide Synthase by Nitric Oxide J. Biol. Chem., March 24, 2006; 281(12): 8197 - 8204. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Munzel, A. Daiber, V. Ullrich, and A. Mulsch Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1551 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Panda, M. Chawla-Sarkar, C. Santos, T. Koeck, S. C. Erzurum, J. F. Parkinson, and D. J. Stuehr Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitor PNAS, July 19, 2005; 102(29): 10117 - 10122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Racasan, B. Braam, H. A. Koomans, and J. A. Joles Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon Am J Physiol Renal Physiol, April 1, 2005; 288(4): F626 - F636. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Cardounel, Y. Xia, and J. L. Zweier Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase: DIFFERENCES IN THE EFFECTS OF MONOMETHYL- AND DIMETHYLARGININES IN THE PRESENCE AND ABSENCE OF TETRAHYDROBIOPTERIN J. Biol. Chem., March 4, 2005; 280(9): 7540 - 7549. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kolodziejski, J.-S. Koo, and N. T. Eissa Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors PNAS, December 28, 2004; 101(52): 18141 - 18146. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Dunbar, Y. Kamada, G. J. Jenkins, E. R. Lowe, S. S. Billecke, and Y. Osawa Ubiquitination and Degradation of Neuronal Nitric-Oxide Synthase in Vitro: Dimer Stabilization Protects the Enzyme from Proteolysis Mol. Pharmacol., October 1, 2004; 66(4): 964 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stuehr Enzymes of the L-Arginine to Nitric Oxide Pathway J. Nutr., October 1, 2004; 134(10): 2748S - 2751S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Stasiv, B. Kuzin, M. Regulski, T. Tully, and G. Enikolopov Regulation of multimers via truncated isoforms: a novel mechanism to control nitric-oxide signaling Genes & Dev., August 1, 2004; 18(15): 1812 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shang, S. Kotamraju, S. V. Kalivendi, C. J. Hillard, and B. Kalyanaraman 1-Methyl-4-phenylpyridinium-induced Apoptosis in Cerebellar Granule Neurons Is Mediated by Transferrin Receptor Iron-dependent Depletion of Tetrahydrobiopterin and Neuronal Nitric-oxide Synthase-derived Superoxide J. Biol. Chem., April 30, 2004; 279(18): 19099 - 19112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Hynes, L. A. Smith, D. M. Richardson, I. Kovesdi, T. O'Brien, and Z. S. Katusic In vivo expression and function of recombinant GTPCH I in the rabbit carotid artery Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H570 - H574. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ido, K. Chang, and J. R. Williamson NADH augments blood flow in physiologically activated retina and visual cortex PNAS, January 13, 2004; 101(2): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Fossel Improvement of Temperature and Flow in Feet of Subjects with Diabetes With Use of a Transdermal Preparation of L-Arginine: A pilot study Diabetes Care, January 1, 2004; 27(1): 284 - 285. [Full Text] [PDF] |
||||
![]() |
E. R. Werner, A. C.F. Gorren, R. Heller, G. Werner-Felmayer, and B. Mayer Tetrahydrobiopterin and Nitric Oxide: Mechanistic and Pharmacological Aspects Experimental Biology and Medicine, December 1, 2003; 228(11): 1291 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kolodziejski, M. B. Rashid, and N. T. Eissa Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase PNAS, November 25, 2003; 100(24): 14263 - 14268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. El-Gayar, H. Thuring-Nahler, J. Pfeilschifter, M. Rollinghoff, and C. Bogdan Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages J. Immunol., November 1, 2003; 171(9): 4561 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Panda, S. Adak, K. S. Aulak, J. Santolini, J. F. McDonald, and D. J. Stuehr Distinct Influence of N-terminal Elements on Neuronal Nitric-oxide Synthase Structure and Catalysis J. Biol. Chem., September 26, 2003; 278(39): 37122 - 37131. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Kone, T. Kuncewicz, W. Zhang, and Z.-Y. Yu Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide Am J Physiol Renal Physiol, August 1, 2003; 285(2): F178 - F190. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Habisch, A. C. F. Gorren, H. Liang, R. C. Venema, J. F. Parkinson, K. Schmidt, and B. Mayer Pharmacological Interference with Dimerization of Human Neuronal Nitric-Oxide Synthase Expressed in Adenovirus-Infected DLD-1 Cells Mol. Pharmacol., March 1, 2003; 63(3): 682 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osawa, E. R. Lowe, A. C. Everett, A. Y. Dunbar, and S. S. Billecke Proteolytic Degradation of Nitric Oxide Synthase: Effect of Inhibitors and Role of hsp90-Based Chaperones J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 493 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Tarpey Sepiapterin Treatment in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1519 - 1521. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |